From Discovery To Development To Delivery
AZBio is committed to building a top-tier life science industry in Arizona.
Arizona has a sizable and rapidly growing bioscience industry. State bioscience firms employed 25,686 in 2016 in 1,310 individual business establishments. Industry employment has grown by 9 percent since 2014, twice the growth rate of the nation, with four of the five major subsectors adding jobs during the period. Both drugs and pharmaceuticals and research, testing and medical labs have experienced double-digit job growth since 2014. Arizona inventors have been awarded nearly 2,000 bioscience-related patents since 2014, among the second quintile of states in patent activity. Since 2015, NIH awards to Arizona institutions have increased, reaching $189 million in FY 2017. (Get The Facts)
AZBio Members Are Making LIFE Bettter
AZBio Members discover, develop, and deliver life-saving and life-changing innovations.
Get Connected With Arizona's Bioindustry
A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on Arizona’s bioscience industry. AZBio membership includes patient advocacy organizations, life science innovators, educators, healthcare partners and leading business organizations. AZBio is the statewide affiliate of the Biotechnology Innovation Organization (BIO) and works in partnership with AdvaMed, MDMA, and PhRMA to advance innovation and to ensure that the value delivered from life-changing and life-saving innovation benefits people in Arizona and around the world.
Success Stories – Good News from Arizona’s BioIndustry
Another honor announced for the 2011 Arizona Bioscience Company of the Year Freedom® Portable Driver for Powering SynCardia’s Total Artificial Heart Shortlisted for “Most Innovative Cardiac Product of the Year”
Acquisition Includes a Novel Cancer Treatment in Clinical Trials for Hematologic Malignancies Micromet’s Proprietary BiTE® Platform has Potential to Improve Treatment in Multiple Tumor Types
Oral Btk inhibitor AVL-292 offers promising potential for treatment of B-cell diseases Avilomics™ Platform enhances drug discovery capabilities
The world’s premiere medical device conference October 1-3, 2012 |Boston, MA Boston Convention & Exhibition Center Panel Submissions for AdvaMed 2012 Now Open
- AZBio Summer Social 2019 at GlobalMed
- Laws of Innovation Series: Negotiating Patent and Know-How License Agreements
- BIO Latin America
- 09/03/2019 - 09/04/2019
- São Paulo
- The Rocky Mountain Life Science Investor & Partnering Conference
- 09/04/2019 - 09/05/2019
- RESI 2019 - Boston